Clinical Trial Update: An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer Patients

View source ↗

Summary

An observational study update assessing hepatic toxicity associated with crizotinib in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Xalkori (crizotinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-Small Cell Lung Cancer | Status: UNKNOWN